AS
EW icon

AM Squared’s Edwards Lifesciences EW Stock Holding History

AM Squared’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$72.6K Buy
+1,100
New +$79.9K 0.16% 52
2024
Q2 		– Sell
-600
Closed -$57.3K – 84
2024
Q1 		$57.3K Buy
+600
New +$50.4K 0.14% 26

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

AM Squared's EW Position: Q3 2024 in Review

AM Squared opened a new position in Edwards Lifesciences (EW) in Q3 2024: 1,100 shares worth $72.6K. The stake represents 0.16% of the portfolio and ranks #52 among its holdings. This is a return to the name: AM Squared previously reported a position in EW as recently as Q1 2024.

AM Squared first reported a position in EW in Q1 2024 and has held it in 2 quarters since. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • AM Squared held 1,100 shares of Edwards Lifesciences worth $72.6K as of Q3 2024.
  • Edwards Lifesciences was a new AM Squared position in Q3 2024.
  • Edwards Lifesciences made up 0.16% of AM Squared's portfolio in Q3 2024, its #52 holding.
  • AM Squared first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 2 quarters since.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.